| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.06 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.097 | 0.6 |